Matches in SemOpenAlex for { <https://semopenalex.org/work/W2087678940> ?p ?o ?g. }
- W2087678940 endingPage "53" @default.
- W2087678940 startingPage "47" @default.
- W2087678940 abstract "An established biochemical index for monitoring therapy in patients with metastatic breast cancer was tested prospectively in a multicentre study. The index uses two serum tumour markers--carcinoembryonic antigen (CEA) and carbohydrate antigen 15-3 (CA15-3) along with erythrocyte sedimentation rate (ESR). 67 patients treated by either endocrine or chemotherapy had CA15-3, CEA and ESR measured at diagnosis of metastases and sequentially during therapy. Two markers, CA15-3 and CEA, were measured on a further 16 patients giving a total of 83 patients who were assessable for CA15-3 and CEA. Of the patients with CA15-3, CEA and ESR measured at diagnosis of metastases 84% (56/67) had elevation of 1 or more markers. During therapy the number with elevated marker(s) rose to 96% (64/67). Changes in the markers were in line with and often pre-dated therapeutic outcome as assessed by the International Union Against Cancer (UICC) criteria both for remission and progression. Patients without elevation of markers on diagnosis subsequently showed a rise in the marker(s) at or before documented disease progression by UICC. The 3 women in whom markers were at no time significantly elevated remain in remission. The results using CA15-3 and CEA were similar but 12% less patients were assessable. CA15-3 and CEA (with and without ESR) provide an objective method to guide therapy in patients with metastatic breast cancer." @default.
- W2087678940 created "2016-06-24" @default.
- W2087678940 creator A5000183024 @default.
- W2087678940 creator A5009525409 @default.
- W2087678940 creator A5012882913 @default.
- W2087678940 creator A5013492364 @default.
- W2087678940 creator A5021982213 @default.
- W2087678940 creator A5035157152 @default.
- W2087678940 creator A5038211119 @default.
- W2087678940 creator A5051980635 @default.
- W2087678940 creator A5054372316 @default.
- W2087678940 creator A5058219705 @default.
- W2087678940 creator A5066067660 @default.
- W2087678940 creator A5073889721 @default.
- W2087678940 creator A5076153882 @default.
- W2087678940 date "1999-01-01" @default.
- W2087678940 modified "2023-10-15" @default.
- W2087678940 title "The objective measurement of remission and progression in metastatic breast cancer by use of serum tumour markers" @default.
- W2087678940 cites W1521808408 @default.
- W2087678940 cites W1950887784 @default.
- W2087678940 cites W1969508967 @default.
- W2087678940 cites W1974523663 @default.
- W2087678940 cites W1983270279 @default.
- W2087678940 cites W1996391780 @default.
- W2087678940 cites W2002905683 @default.
- W2087678940 cites W2003624069 @default.
- W2087678940 cites W2006436367 @default.
- W2087678940 cites W2024028295 @default.
- W2087678940 cites W2057459166 @default.
- W2087678940 cites W2058681718 @default.
- W2087678940 cites W2061807356 @default.
- W2087678940 cites W2070399074 @default.
- W2087678940 cites W2091196063 @default.
- W2087678940 cites W4302451371 @default.
- W2087678940 doi "https://doi.org/10.1016/s0959-8049(98)00297-4" @default.
- W2087678940 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10211087" @default.
- W2087678940 hasPublicationYear "1999" @default.
- W2087678940 type Work @default.
- W2087678940 sameAs 2087678940 @default.
- W2087678940 citedByCount "88" @default.
- W2087678940 countsByYear W20876789402012 @default.
- W2087678940 countsByYear W20876789402013 @default.
- W2087678940 countsByYear W20876789402014 @default.
- W2087678940 countsByYear W20876789402015 @default.
- W2087678940 countsByYear W20876789402016 @default.
- W2087678940 countsByYear W20876789402017 @default.
- W2087678940 countsByYear W20876789402018 @default.
- W2087678940 countsByYear W20876789402020 @default.
- W2087678940 countsByYear W20876789402021 @default.
- W2087678940 countsByYear W20876789402022 @default.
- W2087678940 countsByYear W20876789402023 @default.
- W2087678940 crossrefType "journal-article" @default.
- W2087678940 hasAuthorship W2087678940A5000183024 @default.
- W2087678940 hasAuthorship W2087678940A5009525409 @default.
- W2087678940 hasAuthorship W2087678940A5012882913 @default.
- W2087678940 hasAuthorship W2087678940A5013492364 @default.
- W2087678940 hasAuthorship W2087678940A5021982213 @default.
- W2087678940 hasAuthorship W2087678940A5035157152 @default.
- W2087678940 hasAuthorship W2087678940A5038211119 @default.
- W2087678940 hasAuthorship W2087678940A5051980635 @default.
- W2087678940 hasAuthorship W2087678940A5054372316 @default.
- W2087678940 hasAuthorship W2087678940A5058219705 @default.
- W2087678940 hasAuthorship W2087678940A5066067660 @default.
- W2087678940 hasAuthorship W2087678940A5073889721 @default.
- W2087678940 hasAuthorship W2087678940A5076153882 @default.
- W2087678940 hasConcept C111683008 @default.
- W2087678940 hasConcept C118646709 @default.
- W2087678940 hasConcept C121608353 @default.
- W2087678940 hasConcept C126322002 @default.
- W2087678940 hasConcept C142724271 @default.
- W2087678940 hasConcept C143998085 @default.
- W2087678940 hasConcept C2775930923 @default.
- W2087678940 hasConcept C2776694085 @default.
- W2087678940 hasConcept C2777387746 @default.
- W2087678940 hasConcept C2778143017 @default.
- W2087678940 hasConcept C2779013556 @default.
- W2087678940 hasConcept C2781447364 @default.
- W2087678940 hasConcept C530470458 @default.
- W2087678940 hasConcept C71924100 @default.
- W2087678940 hasConcept C90924648 @default.
- W2087678940 hasConceptScore W2087678940C111683008 @default.
- W2087678940 hasConceptScore W2087678940C118646709 @default.
- W2087678940 hasConceptScore W2087678940C121608353 @default.
- W2087678940 hasConceptScore W2087678940C126322002 @default.
- W2087678940 hasConceptScore W2087678940C142724271 @default.
- W2087678940 hasConceptScore W2087678940C143998085 @default.
- W2087678940 hasConceptScore W2087678940C2775930923 @default.
- W2087678940 hasConceptScore W2087678940C2776694085 @default.
- W2087678940 hasConceptScore W2087678940C2777387746 @default.
- W2087678940 hasConceptScore W2087678940C2778143017 @default.
- W2087678940 hasConceptScore W2087678940C2779013556 @default.
- W2087678940 hasConceptScore W2087678940C2781447364 @default.
- W2087678940 hasConceptScore W2087678940C530470458 @default.
- W2087678940 hasConceptScore W2087678940C71924100 @default.
- W2087678940 hasConceptScore W2087678940C90924648 @default.
- W2087678940 hasIssue "1" @default.
- W2087678940 hasLocation W20876789401 @default.
- W2087678940 hasLocation W20876789402 @default.